BSEBoard Meeting24 Aug 2026 · 24 Aug 2026, 04:40 pm

1. Considered & approved: (i) Director''s Report for the F.Y. ended March 31, 2026 (ii) notice of 24th AGM to be held on September 19, 2026 at 12:30 P.M. through VC/OAVM 2. Fixed date ....

Prism Medico and Pharmacy Ltd · 512217

✦ AI SummaryResults

Prism Medico and Pharmacy Ltd's Board of Directors approved the Director's Report for FY ended March 31, 2026, and the notice of 24th AGM to be held on September 19, 2026. They also fixed the date for closure of Register of Members and Share Transfer Books, and appointed a scrutinizer for e-voting. Additionally, they recommended the re-appointment of Statutory Auditors and Secretarial Auditors, and variation in the objects of the Preferential Issue.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Prism Medico and Pharmacy Ltd - 512217 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Attachments (1)

📄

c5a6549c-30ec-4d62-9b23-ec5e0c2eb1c4.pdf

pdf

Download →
View document text
PRISM MEDICO AND PHARMACY LIMITED CIN: L24100HP2002PLC009299; Email Id: investorgrievancewmcl@gmail.com Registered Office: Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030. Date: 24.08.2026 To, T o, Department of Corporate Services, Listing Department, BSE LIMITED Metropolitan Stock Exchange of India Limited P. J. Towers, Dalal Street, (MSED Mumbai, Maharashtra-400001 Vibgyor Towers, 4 Floor, Plot Number C 62, G - Block, Opposite Trident Hotel, Bandra Kurla Complex, ISIN : INE730E01016 Bandra (E), Mumbai, Maharashtra-400098. Scrip Code: 512217 SYMBOL: PRISMMEDI Subject: Outcome of the Board Meeting - Disclosure under Regulation 30 of the SEBI- (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 24% August, 2026) which commenced at 01:00 P.M. and concluded at 04:00 P.M. have inter alia approved the following: » Considered and approved the Director's Report along with all necessary annexures thereof, for the Financial Year ended March 31, 2026; Considered and approved the notice of 24 Annual General Meeting of the company to be held on Saturday, the 19% day of September, 2026 at 12:30 P.M. through Video Conferencing/Other Audio-Visual Means; » Fixed the date for closure of Register of Members and Share Transfer Books from 13% September, 2026 to 19% September, 2026 (both days inclusive) for the purpose of 24+ Annual General Meeting; >» Fixed 12% September, 2026 as the cut-off date to record the entitlement of the shareholders, to cast their votes electronically for the ensuing 24 Annual General Meeting of the company; > Approved the appointment of Mr. Mast Ram Chechi proprietor of M/s. M. R. Chechi and Associates, Company Secretaries, Chandigarh as scrutinizer to conduct e-voting process of 24th Annual General Meeting of the company; » Considered and recommended the re-appointment of M/s. Garg Mendiratta and Associates, Chartered Accountants as the Statutory Auditors of the company and fix their remuneration. > Considered and recommended the appointment of M/s. SDK & Associates, Practicing Company Secretaries as the Secretarial Auditors of the Company for five financial years from Financial Year 2026-2027 to Financial Year 2030-2031. Considered and recommended to invest the funds of the company as per the provisions of Section 186 of the Companies Act, 2013. >» Considered and recommended the variation in the objects of the Preferential Issue and in ~ the utilisation of the proceeds thereof, as approved by the members in the Extraordinary General Meeting held on March 20, 2026 You are requested to kindly take the same on record and oblige. Thanking You. Yours Truly, FOR PRISM MEDICO AND PHARMACY LIMITED ye’ ft BS aL A- DAVENDER SINGH _ DIRECTOR DIN: 09447213,